Caffeine and sulfadiazine interact differently with human serum albumin: A combined fluorescence and molecular docking study.

Mullah Muhaiminul Islam, Vikash K Sonu, Pynsakhiat Miki Gashnga, N Shaemningwar Moyon, Sivaprasad Mitra

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 2016;152():23-33

PMID: 26186394

Abstract

The interaction and binding behavior of the well-known drug sulfadiazine (SDZ) and psychoactive stimulant caffeine (CAF) with human serum albumin (HSA) was monitored by in vitro fluorescence titration and molecular docking calculations under physiological condition. The quenching of protein fluorescence on addition of CAF is due to the formation of protein-drug complex in the ground state; whereas in case of SDZ, the experimental results were explained on the basis of sphere of action model. Although both these compounds bind preferentially in Sudlow's site 1 of the protein, the association constant is approximately two fold higher in case of SDZ (∼4.0×10(4)M(-1)) in comparison with CAF (∼9.3×10(2)M(-1)) and correlates well with physico-chemical properties like pKa and lipophilicity of the drugs. Temperature dependent fluorescence study reveals that both SDZ and CAF bind spontaneously with HSA. However, the binding of SDZ with the protein is mainly governed by the hydrophobic forces in contrast with that of CAF; where, the interaction is best explained in terms of electrostatic mechanism. Molecular docking calculation predicts the binding of these drugs in different location of sub-domain IIA in the protein structure.

Copyright © 2015 Elsevier B.V. All rights reserved.

Address: Centre for Advanced Studies, Department of Chemistry, North-Eastern Hill University, Shillong 793 022, India.; Centre for Advanced Studies, Department of Chemistry, North-Eastern Hill University, Shillong 793 022, India. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.